Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$9.99
▲ $0.00 (+0.0%)
Market data updated: 09/15 10:07 AM
News analyzed: 09/15/2026
Market Cap
Not available
Day Range
$9.99 - $9.99
52-Week Range
$9.84 - $9.99
Beta
—
Next Earnings
—
+1.2% (1Y)
🟡 Moderate
Strengths: 7/12 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Daily volatility (ATR)
ATR: 0.0% of price
Risk
Biggest negative driver
Relative strength vs. S&P 500
-1.6% over the last 3 months relative to the index
Technical
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 0 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 0
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
57
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
No data available
Quality
No data available
Value
No data available
Momentum
59
Risk
58
Sentiment
50
Fundamental
No data available
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
🌡️ Emotional Temperature
23
🎯 Conviction (vs. Emotion)
50
Psychology
100
Fundamentals
—
Technical
59
Valuation
—
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
+1%
Market Narrative
44
Fundamental Reality
50
Narrative Gap
-6
🧠 StockIQ Psychologist
The market’s near-touch to resistance (0.1%) dominates psychology, indicating traders are fixated on past highs despite neutral momentum and volume. While FOMO exists at moderate levels, it lacks extreme momentum or sentiment to drive aggressive buying. The key question is whether this anchoring will hold as price tests resistance—or if traders abandon the anchor under pressure. The narrative gap (-6) suggests reality slightly outpaces perception, but anchoring may amplify resistance as a psychological barrier.
Updated: 09/09/2026, 05:12 AM
What could change this?
📈 13D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Morgan Housel — 100/100
🔴 Weakest match
Samuel Armstrong Nelson — 2/100
🗣️ Why do they disagree?
The stark contrast between Morgan Housel’s near-perfect score (100) and the rest of the methodologies highlights a fundamental divide in how this stock is evaluated. Housel’s model, focused on quiet compounding and patient holding, sees AACO as a clear, low-noise opportunity—ideal for long-term investors who prioritize consistency over speculation. Meanwhile, methodologies like Charles Mackay’s (82) and Thorstein Veblen’s (80) still find merit, flagging no crowd-driven hype or misaligned growth, but they’re more cautious, recognizing potential blind spots. The middle tier—from Gerald Loeb (74) to Howard Marks (72)—balances risk and reward, acknowledging reasonable capital preservation but lacking the decisive edge of Housel’s framework. At the lower end, the scores (50 or below) reflect a lack of concrete data for valuation, growth, or dividend analysis, leaving methodologies like Graham’s, Fisher’s, or Smith’s unable to form a definitive opinion. The divergence underscores whether AACO’s appeal lies in its quiet fundamentals (Housel’s view) or whether it’s too murky for traditional fundamental or cyclical frameworks.
Morgan Housel
The Psychology of Money (2020)
🟢 100
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 80
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 74
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 72
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 69
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 52
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 51
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 50
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🔴 34
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 31
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 15
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 2
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Based on the last 106 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (6 bullish · 5 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a trading range, but the picture isn't yet clear enough on the likely direction.
Low confidence
$9.92
Range Bottom
$9.99
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Sentiment based on basic keywords (not AI) — 0 positive, 0 neutral, 0 negative out of the last 0 articles.
No recent articles found for this stock.
StockIQ doesn't currently have enough real data to compute a reliable score for Abony Acquisition Corp. I - Class A Ordinary Share (AACO) — only 3 of 7 categories are available right now. Rather than show a misleading number, this page shows which data is missing instead.
StockIQ doesn't give buy/sell recommendations — and for AACO specifically, there currently isn't enough real data (only 3 of 7 categories available) to state even a factual score reliably. Check back once more data is available.
AACO's technical score is 59/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: ATR: 0.0% of price; Price is above the 50-day average; MACD histogram is positive — rising momentum.
Based on the real signals StockIQ computed: -1.6% over the last 3 months relative to the index; CMF 20 days: -0.83; RSI 74.6 — approaching overbought territory.
StockIQ has no recorded dividend payment history for AACO.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 4 purchases and 0 sales out of the last 4 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Abony Sponsor I LLC | Open Market Purchase | 20.2.2026 | 465,000 | +465,000 | — |
| Abony Lorne | Open Market Purchase | 20.2.2026 | 465,000 | +465,000 | — |
| Abony Lorne | Open Market Purchase | 20.2.2026 | 465,000 | +465,000 | — |
| Abony Sponsor I LLC | Open Market Purchase | 20.2.2026 | 465,000 | +465,000 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
332 shares short as of 2026-08-31 · vs. 330 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
70.2% of trading volume this week was short selling, vs. 90.0% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology